Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Kaiser Permanente launches osteoporosis prevention campaign

Encouraging everyone to “Embrace Your Inner Strength,” Kaiser Permanente has launched a campaign throughout Southern California aimed at getting teenagers, seniors and everyone in between to get serious about building up their skeletons and preventing osteoporosis.

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

Researchers to analyze role of air pollution in respiratory and cardiovascular diseases

A new mobile air research laboratory will help a team of researchers led by a Michigan State University professor better understand the damaging health effects of air pollution and why certain airborne particles - emitted from plants and vehicles - induce disease and illness.

8 Oct 2009

Researchers succeed in engineering human tissue patches from stem cells

University of Washington (UW) researchers have succeeded in engineering human tissue patches free of some problems that have stymied stem-cell repair for damaged hearts.

8 Oct 2009

New study to assess the risk of heart disease in diabetics

In a new international partnership, Dr. Randy Nelson, a researcher at Arizona State University's Biodesign Institute, and Dr. Tai E-Shyong , associate professor at Singapore's National University Hospital, National University Health System (NUHS), have teamed up to assess the risk of heart disease in diabetics with greater accuracy.

8 Oct 2009

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.

8 Oct 2009

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

International Diabetes Federation Middle East and North Africa Region (MENA) today launched a diabetes action plan, marking a major step forward towards optimal disease management in type 2 diabetes. The MENA action plan aims to improve the prevention, treatment and care of diabetes, which has reached epidemic proportions in the region and has overtaken wider communicable diseases as a health risk.

8 Oct 2009

FDA approves Daiichi Sankyo's sNDA for Welchol

Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.

7 Oct 2009

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

Arizona Heart Institute, a world leading medical facility specializing in diagnosis, treatment and prevention of heart and vascular disease, and Arizona Research Center, a dedicated provider of clinical research studies, announce a partnership in the advancement of cardiovascular therapies.

7 Oct 2009

2010 Medco Medicare Prescription Plan to identify lower-cost medication options

Medco Health Solutions, Inc. (NYSE: MHS) is helping seniors in this tough economy find smart solutions for getting the most value out of their Medicare prescription drug plan.

7 Oct 2009

Working Nights Spanish Calendar for Hispanics to improve their security and wellbeing

Circadian Age, Inc. – ‘Working Nights’ – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is announcing a new Spanish calendar. The 2010 Working Nights Spanish Calendar offers organizations with Hispanic workers the opportunity to show added concern about the health and safety of this group of employees, by providing them with educational material in their own language, to use at home.

7 Oct 2009

Scientists develop new molecule that can deliver genetic-based drugs into cells

Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can travel into cells, deliver genetic cargo, and packs a beacon so scientists can follow its movements in living systems.

7 Oct 2009

FDA provides Genzyme a complete response letter for Clolar NDA

Genzyme Corporation announced today that the FDA provided a complete response letter regarding the company's supplemental New Drug Application for Clolar® (clofarabine) in previously untreated older adult patients with acute myeloid leukemia (AML) and at least one unfavorable baseline prognostic factor. The agency recommended a randomized, controlled clinical study be conducted for label expansion of Clolar in this indication.

7 Oct 2009

B-vitamin supplements do not prevent heart attack

B-vitamin supplements should not be recommended for prevention of heart disease, say scientists. A Cochrane Systematic Review has shown these supplements do not reduce the risk of developing or dying from the disease.

7 Oct 2009

Gene mutation linked to age-related hearing loss

Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

7 Oct 2009

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.

6 Oct 2009

Fat and muscle mass may contribute to diabetes risk

Fat and muscle mass, as potentially determined by a person's ethnic background, may contribute to diabetes risk, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

6 Oct 2009

Framingham Heart Study receives $1M grant from the National Heart, Lung, and Blood Institute

Boston University School of Medicine's (BUSM) Framingham Heart Study (FHS) has received a two-year $1M challenge grant from the National Heart, Lung, and Blood Institute.

6 Oct 2009

Winner of 2009 NAMS award

Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS).

6 Oct 2009

Sit-and-reach test to gauge age-related arterial stiffness

How far you can reach beyond your toes from a sitting position - normally used to define the flexibility of a person's body - may be an indicator of how stiff your arteries are.

6 Oct 2009

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Kaiser Permanente launches osteoporosis prevention campaign

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

Researchers to analyze role of air pollution in respiratory and cardiovascular diseases

Researchers succeed in engineering human tissue patches from stem cells

New study to assess the risk of heart disease in diabetics

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

FDA approves Daiichi Sankyo's sNDA for Welchol

Arizona Heart Institute partners with Arizona Research Center for the advancement of cardiovascular therapies

2010 Medco Medicare Prescription Plan to identify lower-cost medication options

Working Nights Spanish Calendar for Hispanics to improve their security and wellbeing

Scientists develop new molecule that can deliver genetic-based drugs into cells

FDA provides Genzyme a complete response letter for Clolar NDA

B-vitamin supplements do not prevent heart attack

Gene mutation linked to age-related hearing loss

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Fat and muscle mass may contribute to diabetes risk

Framingham Heart Study receives $1M grant from the National Heart, Lung, and Blood Institute

Winner of 2009 NAMS award

Sit-and-reach test to gauge age-related arterial stiffness

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in